Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4ds4n | IM / LA |
Patient has completed Heplisav B series of 2 in 2023, however, RPH didn't notice and has given #1 Twinrix. This was discovered when pt came back for #2 dose. No issue occurred.